NCT00945295 - Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Upper Limb Spasticity

Interventions

DRUG

Botulinum toxin type A, BoNT-A

Participants will receive IM injections of BoNT-A between 200 and 400 Units with the total dose not to exceed 6 U / kg. The primary targets for BoNT-A injection are the wrist and finger flexor muscles (flexor carpi radialis, flexor carpi ulnaris, flexor digitorum profundus, flexor digitorum superficialis).

OTHER

Rehabilitation Therapy

Rehabilitation therapy

Trial Locations (1)

87108

New Mexico VA Health Care System, Albuquerque